Hafeez Ikram

Title: Hafeez Ikram: Innovator in Hepatitis B Vaccine Development

Introduction

Hafeez Ikram is a notable inventor based in Corona, NY (US). He has made significant contributions to the field of immunology, particularly in the development of synthetic peptides for vaccine applications. With a total of 2 patents, his work focuses on creating effective immunizing agents against the hepatitis B virus.

Latest Patents

Hafeez Ikram's latest patents include a synthetic antigenic peptide derived from hepatitis B surface antigen. This innovative synthetic peptide evokes an immunological response and interacts with antibodies to hepatitis B surface antigen (HBsAg). The peptide serves as an active component in vaccines, producing protective antibodies in vivo against the hepatitis B virus. The specific amino acid sequence of the synthetic peptide includes Arg Trp Met Met Leu Arg Arg (I) and preferably features Gly Tyr Arg Trp Met Met Leu Arg Arg Phe Gly (II).

Career Highlights

Hafeez Ikram is associated with the New York Blood Center, Inc., where he applies his expertise in immunology and peptide synthesis. His work has the potential to significantly impact vaccine development and public health.

Collaborations

Hafeez has collaborated with notable colleagues, including John Vnek and Alfred M Prince, contributing to advancements in his field.

Conclusion

Hafeez Ikram's innovative work in synthetic peptides for hepatitis B vaccines showcases his dedication to improving immunological responses and public health. His contributions are vital in the ongoing fight against viral infections.